In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PACEMAKER/CELLULAR PHONE EMI BENCH TESTING PROTOCOL WILL BE DEVELOPED

This article was originally published in The Gray Sheet

Executive Summary

PACEMAKER/CELLULAR PHONE EMI BENCH TESTING PROTOCOL WILL BE DEVELOPED over the next several months by pacemaker manufacturers and the Cellular Telecommunications Industry Association (CTIA), Medtronic VP Chuck Swanson said at an Oct. 5 heating of the House Government Operations/Information, Justice, Transportation, and Agriculture Subcommittee. Testifying on behalf of the Health Industry Manufacturers Association and the pacemaker industry, Swanson reported that pacer manufacturers and CTIA "have agreed to work...to develop the best protocol" for bench testing "to evaluate the effects of cellular phones on pacemaker operations." Swanson noted that FDA will review and comment on the protocol once it is developed. Representatives of the medical community, primarily cardiologists, may also participate in protocol development, he said.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel